The Latest Breaking News from HIV

Research on HIV, cancer and infertility is being quietly dismantled under Trump’s anti-DEI agenda.

Gilead Sciences shares rose Friday after the Supreme Court tossed out a challenge that would have impacted HIV PrEP drugs.

A new Idaho law restricting public benefits for undocumented immigrants is facing a legal challenge

Seven newborn babies are found to have HIV every day in Papua New Guinea despite the availability of preventative drugs.

As lawmakers in Washington debate the new federal budget, one group is bracing for devastating consequences: Americans living with HIV. The proposed GOP-led budget calls...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new treatment marks a major advancement in expanding prevention options for people at risk of HIV infection.

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the people who need it? Rachel Schraer reports

US Congress member Marjorie Taylor Greene purchased shares of Adobe, Netflix, Snowflake, ServiceNow, NextEra Energy, and Gilead Sciences on 6th June.

IN FULL

Strategy may lead to new vaccines that only need to be taken once

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication